AP NEWS

Global Drug Discovery Services Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023): A $15.36 Billion Opportunity - ResearchAndMarkets.com

November 7, 2018

DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Global Drug Discovery Services Market - by Type, Process, Drug Type, Therapeutic Area, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)” report has been added to ResearchAndMarkets.com’s offering.

The global drug discovery services market was USD 8.17 billion in 2017 and is estimated to reach USD 15.36 billion by 2023 at a CAGR of 11.1% during the forecast period.

The demand and requirement for novel drugs and a growing list of chronic illness are the driving factors for market growth. The increasing aging population with chronic illness, developments in the field of molecular biology, biotechnology, genomics, and nanotechnology have augmented the investments in the global drug discovery services market.

The rise in technological advancements and innovations in the field of pharmaceutical and biotech plays a crucial role in the development and innovation of new drugs. Stringent regulations in some regions on drug discovery services, huge capital involved in the discovery and development of the drugs and usage of animals in testing are hampering the market growth.

Industry Trends and Updates

Merck launched Zinplava for the prevention of recurrence of Clostridium difficile infection in adults. BioCryst Pharmaceuticals and Idera Pharmaceuticals planned for a merger to develop drugs for patients with rare diseases. AstraZeneca and Imperial College London joined hands in investigating biological drivers for respiratory diseases, such as asthma and chronic obstructive pulmonary disease. Abbott Laboratories and Reata Pharmaceuticals announced their worldwide collaboration to jointly develop and commercialize Reata’s portfolio of second-generation oral antioxidant inflammation modulators (AIMs). Abbott Park and NeuroSearch have reached an agreement to jointly discover, develop, and commercialize novel compounds for the treatment of central and peripheral nervous system disorders. Companies ProfiledAbbott Laboratories Inc.Agilent Technologies Inc.Albany Molecular Research Inc. (AMRI)AstraZeneca PLCBoehringer Ingelheim GmbHDiscoverXF. Hoffmann-La Roche Ltd.GlaxoSmithKline LLCGVK BiosciencesJubilant BiosysMerck & Co. Inc.Pfizer Inc.SelvitaShimadzu Corp.and more...

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Drug Discovery Services Market Segmentation, Forecasts and Trends - by Type

6. Global Drug Discovery Services Market Segmentation, Forecasts and Trends - by Process

7. Global Drug Discovery Services Market Segmentation, Forecasts and Trends - by Drug Type

8. Global Drug Discovery Services Market Segmentation, Forecasts and Trends - by Therapeutic Area

9. Global Drug Discovery Services Market Segmentation, Forecasts and Trends - by Region

10. Company Market Share Analysis

11. Company Profiles

12. Industry Structure

13. Global Drug Discovery Services Market - The Road Ahead

For more information about this report visit https://www.researchandmarkets.com/research/r8d6wv/global_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005392/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/07/2018 05:08 AM/DISC: 11/07/2018 05:08 AM

http://www.businesswire.com/news/home/20181107005392/en

AP RADIO
Update hourly